Neonatal Platelets Are Less Reactive than Adult Platelets to Physiological Agonists in Whole Blood

 

PDF Download Buy Article Permissions and Reprints

Summary

Previous studies have reported that the platelets of healthy term neonates have either diminished or normal reactivity compared to the platelets of adults. To circumvent the methodologic problems of previous studies, we used a whole blood flow cytometric method to study neonatal platelet reactivity to thrombin, a combination of ADP and epinephrine, and U46619 (a stable thromboxane A₂ analogue). Inclusion in the assay of the peptide GPRP (an inhibitor of fibrin polymerization) enabled us to study platelet reactivity to human α-thrombin in whole blood. Umbilical cord blood and day 1 peripheral blood were collected from 30 healthy term neonates and compared to peripheral blood from 20 normal adults. In whole blood samples without added agonist, there were no significant differences between neonates and adults in the platelet binding of monoclonal antibodies 6D1 (GPIb-specific) or 7E3 (GPIIb-IIIa complex-specific). As determined by S12 (a P-selectin-specific monoclonal antibody), neither neonates nor adults had circulating degranulated platelets. However, in both cord and peripheral whole blood samples, neonatal platelets were significantly less reactive than adult platelets to thrombin, ADP/epinephrine, and U46619, as determined by the extent of increase in the platelet surface expression of P-selectin and the GPIIb-IIIa complex, and the extent of decrease in the platelet surface expression of the GPIb-IX complex. For example, as compared to maximal platelet surface P-selectin in adults (with thrombin 10 U/ml), thrombin 1 U/ml resulted in platelet surface P-selectin of 95 ± 2% (mean ± S.E.M.) in adult peripheral blood, but only 70 ± 4% in cord blood and 70 ± 3% in neonatal peripheral blood (p <0.0001). Thrombin 0.1 U/ml resulted in platelet surface P-selectin of 49 ± 4% in adult peripheral blood, but only 10 ± 2% in cord blood and 17 ± 2% in neonatal peripheral blood (p α0.0001). Similar results were obtained in a washed platelet system. In summary: 1) Compared to adult controls, neonatal platelets are hyporeactive to thrombin, a combination of ADP and epinephrine, and a thromboxane A₂ analogue in the physiologic milieu of whole blood. 2) The hyporeactivity of neonatal platelets compared to adult platelets is the result of a defect intrinsic to neonatal platelets. 3) Whole blood flow cytometry is particularly advantageous for neonatal studies because only 5 μl of blood per assay is required.

• References

• 1 Andrew M, Schmidt B. Hemorrhagic and thrombotic complications in children. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Ed. 3 Colman RW, Hirsh J, Marder VJ, Salzman EW. eds J. B. Lippincott; Philadelphia: 1994. pp 989-1022
  Google Scholar
• 2 Michelson AD. Neonatal thrombosis and hemorrhage. In: Thrombosis and Hemorrhage. Loscalzo J, Schafer AI. eds Blackwell: Cambridge: 1994. pp 999-1026
  Google Scholar
• 3 Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr HematolOncol 1990; 12: 95-104
  PubMedGoogle Scholar
• 4 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen D, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-172
  PubMedGoogle Scholar
• 5 Corrigan Jr JJ. Neonatal thrombosis and the thrombolytic system: pathophysiology and therapy. Am J Pediatr HematolOncol 1988; 10: 83-91
  PubMedGoogle Scholar
• 6 Corrigan JJ. Neonatal coagulation disorders. In: Perinatal Hematology. Alter BP. ed Churchill Livingstone; New York: 1989. pp 165-193
  Google Scholar
• 7 Hathaway WE. Haemostatic disorders in the newborn. In: Haemostasis and Thrombosis. 2nd ed Bloom AL, Thomas DP. eds Churchill Livingstone; Edinburgh: 1987. pp 554-569
  Google Scholar
• 8 Mull MM, Hathaway WE. Altered platelet function in newborns. Pediatr Res 1970; 4: 229-237
  CrossrefPubMedGoogle Scholar
• 9 Whaun JM. The platelet of the newborn infant. 5-Hydroxytryptamine uptake andrelease.Thromb Diath Haemorrh 1973 30. 327-333
  PubMedGoogle Scholar
• 10 Corby DG, Zuck TF. Newborn platelet dysfunction: astorage pool and release defect. Thromb Haemost 1976; 36: 200-207
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Ts’ao CH, Green D, Schultz K. Function and ultrastructure of platelets of neonates: enhanced ristocetin aggregation of neonatal platelets. Br J Haematol 1976; 32: 225-233
  CrossrefPubMedGoogle Scholar
• 12 Corby DG, O’Barr TP. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine. Dev Pharmacol Ther 1981; 2: 215-225
  CrossrefPubMedGoogle Scholar
• 13 Andrews NP, Broughton Pipkin F, Heptinstall S. Blood platelet behaviour in mothers and neonates. Thromb Haemost 1985; 53: 428-432
  Article in Thieme ConnectPubMedGoogle Scholar
• 14 Suarez CR, Gonzales J, Mendez C, Fareed J, Fresco R, Walenga J. Neonatal and maternal platelets: activation at time of birth. Am J Hematol 1988; 29: 18-21
  CrossrefPubMedGoogle Scholar
• 15 Israels SJ, Daniels M, McMillan EM. Deficient collagen-induced activation in the newborn platelet. Pediatr Res 1990; 27: 337-343
  CrossrefPubMedGoogle Scholar
• 16 Ahlsten G, Ewald U, Tuvemo T. Arachidonic acid-induced aggregation of platelets from human cord blood compared with platelets from adults. Biol Neonate 1985; 47: 199-204
  CrossrefPubMedGoogle Scholar
• 17 Jones CR, McCabe R, Hamilton CA, Reid JL. Maternal and fetal platelet responses and adrenoceptor binding characteristics. Thromb Haemost 1985; 53: 95-98
  Article in Thieme ConnectPubMedGoogle Scholar
• 18 Gader AM, Bahakim H, Jabbar FA, Lamboume AL, Gaafar TH, Edrees YB. Dose-response aggregometry in maternal/neonatal platelets. Thromb Haemost 1988; 60: 314-318
  Article in Thieme ConnectPubMedGoogle Scholar
• 19 Abrams C, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991; 65: 467-473
  Article in Thieme ConnectPubMedGoogle Scholar
• 20 Michelson AD. Platelet activation by thrombincan be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical studies. Blood Coagul Fibrinolysis 1994; 5: 121-131
  CrossrefPubMedGoogle Scholar
• 21 Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-315
  PubMedGoogle Scholar
• 22 Michelson AD, Ellis PA, Barnard MR, Made GB, Viles AF, Kestin AS. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, ADP or an in vivo wound. Blood 1991; 77: 770-779
  PubMedGoogle Scholar
• 23 Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, Birji-niuk V, Ouimet H, Pasche B, Nelson MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD. The platelet function defect ofcardiopulmonary bypass. Blood 1993; 82: 107-117
  PubMedGoogle Scholar
• 24 Kestin AS, Ellis PA, Barnard MR, Errichetti AS, Rosner BA, Michelson AD. The effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993; 88: 1502-1511
  CrossrefPubMedGoogle Scholar
• 25 Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-886
  CrossrefPubMedGoogle Scholar
• 26 Bevilacqua M, Butcher E, Furie B, Gallatin M, Gimbrone M, Harlan J, Kishimoto K, Lasky L, McEver R, Paulson J, Rosen S, Seed B, Siegelman M, Springer T, Stoolman L, Tedder T, Varki A, Wagner D, Weissman I, Zimmerman G. Selectins: a family of adhesion receptors. Cell 1991; 67: 233
  CrossrefPubMedGoogle Scholar
• 27 Knapp W, Dorken B, Rieber P, Schmidt RE, Stein H, von dem Borne AEGKr. CD antigens 1989. Blood 1989; 74: 1448-1450
  PubMedGoogle Scholar
• 28 Hsu-Lin S-C, Berman CL, Furie BC, August D, Furie B. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem 1984; 259: 9121-9126
  PubMedGoogle Scholar
• 29 McEver RP. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 1990; 16: 73-80
  PubMedGoogle Scholar
• 30 Coller BS, Peerschke El, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110
  PubMedGoogle Scholar
• 31 Michelson AD, Loscalzo J, Melnick B, Coller BS, Handin RI. Partial characterization of a binding site for von Willebrand factor on glycocalicin. Blood 1986; 67: 19-26
  PubMedGoogle Scholar
• 32 Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein Ilb/IIIa complex. J Clin Invest 1985; 76: 101-108
  CrossrefPubMedGoogle Scholar
• 33 Gatter KC, Cordell JL, Turley H, Heryet A, Kieffer N, Anstee DJ, Mason DY. The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology 1988; 13: 257-267
  CrossrefPubMedGoogle Scholar
• 34 Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA 1978; 75: 3085-3089
  CrossrefPubMedGoogle Scholar
• 35 Plow EF, Marguerie G. Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline. Proc Natl Acad Sci USA 1982; 79: 3711-3715
  CrossrefPubMedGoogle Scholar
• 36 Ault KA, Rinder HM, Mitchell JG, Rinder CS, Lambrew CT, Hillman RS. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 198 (10) 448-455
  PubMedGoogle Scholar
• 37 Michelson AD, Barnard MR. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 1987; 70: 1673-1678
  PubMedGoogle Scholar
• 38 Yamamoto N, Greco NJ, Barnard MR, Tanoue K, Yamazaki H, Jamieson GA, Michelson AD. Glycoprotein Ib (GPIb)-dependent and GPIb-indepen-dent pathways of thrombin-induced platelet activation. Blood 1991; 77: 1740-1748
  PubMedGoogle Scholar
• 39 Levine SP. Secreted platelet proteins as markers for pathological disorders. In: Biochemistry of platelets Phillips DR, Shuman MA. eds Academic Press; Orlando: 1986: 378-415
• 40 Kinlough-Rathbone RL, Packham MA, Mustard JF. Platelet aggregation. In: Measurements of platelet function Harker LA, Zimmerman TS. eds Churchill Livingstone; New York: 1983: 64-91
• 41 Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 1991; 87: 571-580
  CrossrefPubMedGoogle Scholar
• 42 LaRosa CA, Rohrer MJ, Rodino LJ, Benoit SE, Barnard MR, Michelson AD. Human neutrophil cathepsin G is a potent platelet activator. J Vase Surg 1994; 19: 306-319
  CrossrefPubMedGoogle Scholar
• 43 Hansen SR, Harker LA. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin PPACK. Proc Natl Acad Sci USA 1988; 85: 3184-3188
  CrossrefPubMedGoogle Scholar
• 44 Eidt JF, Allison P, Nobel S, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 1989; 84: 18-27
  CrossrefPubMedGoogle Scholar
• 45 Kelly AB, Marzec UM, Krupski W, Bass A, Cadroy Y, Hanson SR, Harker LA. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 1991; 77: 1006-1012
  PubMedGoogle Scholar
• 46 Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein Ilb-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-11114
  PubMedGoogle Scholar
• 47 Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-843
  PubMedGoogle Scholar
• 48 Michelson AD. Thrombin-induced down-regulation of the platelet membrane glycoprotein Ib-IX complex. Semin Thromb Hemost 1992; 18: 18-27
  Article in Thieme ConnectPubMedGoogle Scholar
• 49 Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312
  CrossrefPubMedGoogle Scholar
• 50 Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75: 550-554
  PubMedGoogle Scholar
• 51 Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848-851
  CrossrefPubMedGoogle Scholar
• 52 Ruggeri ZM. The platelet glycoprotein Ib-IX complex. Prog Hemost Thromb 1991; 10: 35-68
  PubMedGoogle Scholar
• 53 Schmidt B, Mitchell L, Ofosu FA, Andrew M. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma. Thromb Haemost 1989; 62: 1074-1077
  Article in Thieme ConnectPubMedGoogle Scholar
• 54 Andrew M, Mitchell L, Berry L, Paes B, Delorme M, Ofosu F, Burrows R, Khambalia B. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest 1992; 89: 321-326
  CrossrefPubMedGoogle Scholar
• 55 Gelman B, Setty YBN, Amin-Hanjani S, Tyrala E, Reece A, Stuart MJ. Impaired mobilization of intracellular calcium in neonatal platelets. Thromb Haemost 1993; 69: 1310 (Abstract)
  PubMedGoogle Scholar
• 56 Michelson AD. Bleeding associated with cardiopulmonary bypass in children. Int J Ped Hem Oncol 1994; 1: 147-158
  PubMedGoogle Scholar